Literature DB >> 15105128

Trypanocidal activity of melamine-based nitroheterocycles.

Mhairi L Stewart1, Gorka Jimenez Bueno, Alessandro Baliani, Burkhard Klenke, Reto Brun, Janice M Brock, Ian H Gilbert, Michael P Barrett.   

Abstract

A series of nitroheterocyclic compounds were designed with linkages to melamine or benzamidine groups that are known substrates of the P2 aminopurine and other transporters in African trypanosomes of the brucei group. Several compounds showed in vitro trypanotoxicity with 50% inhibitory concentrations in the submicromolar range. Although most compounds interacted with the P2 transporter, as judged by their ability to inhibit adenosine transport via this carrier, uptake through this route was not necessary for activity since TbAT1-null mutant parasites, deficient in this transporter, retained sensitivity to these drugs. One compound, a melamine-linked nitrofuran, also showed pronounced activity against parasites in mice. Studies into the mode of action of this compound indicated that neither reductive, nor oxidative, stress were related to its trypanocidal activity ruling out a genotoxic effect in T. brucei, distinguishing it from some other, mammalian cell toxic, trypanocidal nitroheterocycles.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15105128      PMCID: PMC400563          DOI: 10.1128/AAC.48.5.1733-1738.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  38 in total

1.  Antigenic analysis in the Trypanosoma brucei group, using the agglutination reaction.

Authors:  M P CUNNINGHAM; K VICKERMAN
Journal:  Trans R Soc Trop Med Hyg       Date:  1962-01       Impact factor: 2.184

2.  Nitrofurazone in the treatment of sleeping sickness due to Trypanosoma rhodesiense.

Authors:  F I APTED
Journal:  Trans R Soc Trop Med Hyg       Date:  1960-05       Impact factor: 2.184

3.  Nitrofurazone therapy of Trypanosoma gambiense sleeping sickness in man.

Authors:  F EVENS; K NIEMEGEERS; A PACKCHANIAN
Journal:  Am J Trop Med Hyg       Date:  1957-07       Impact factor: 2.345

4.  A role for RAD51 and homologous recombination in Trypanosoma brucei antigenic variation.

Authors:  R McCulloch; J D Barry
Journal:  Genes Dev       Date:  1999-11-01       Impact factor: 11.361

5.  An approach to use an unusual adenosine transporter to selectively deliver polyamine analogues to trypanosomes.

Authors:  C K Tye; G Kasinathan; M P Barrett; R Brun; V E Doyle; A H Fairlamb; R Weaver; I H Gilbert
Journal:  Bioorg Med Chem Lett       Date:  1998-04-07       Impact factor: 2.823

Review 6.  N-acetylcysteine: pharmacological considerations and experimental and clinical applications.

Authors:  I A Cotgreave
Journal:  Adv Pharmacol       Date:  1997

7.  A nucleoside transporter from Trypanosoma brucei involved in drug resistance.

Authors:  P Mäser; C Sütterlin; A Kralli; R Kaminsky
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

Review 8.  The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes.

Authors:  M P Barrett; A H Fairlamb
Journal:  Parasitol Today       Date:  1999-04

9.  Megazol combined with suramin: a chemotherapy regimen which reversed the CNS pathology in a model of human African trypanosomiasis in mice.

Authors:  B Enanga; M Keita; G Chauvière; M Dumas; B Bouteille
Journal:  Trop Med Int Health       Date:  1998-09       Impact factor: 2.622

10.  Effect of megazol on Trypanosoma brucei brucei acute and subacute infections in Swiss mice.

Authors:  B Bouteille; A Marie-Daragon; G Chauvière; C de Albuquerque; B Enanga; M L Dardé; J M Vallat; J Périé; M Dumas
Journal:  Acta Trop       Date:  1995-10       Impact factor: 3.112

View more
  12 in total

1.  Cell-penetrating peptide TP10 shows broad-spectrum activity against both Plasmodium falciparum and Trypanosoma brucei brucei.

Authors:  Romanico B G Arrighi; Charles Ebikeme; Yang Jiang; Lisa Ranford-Cartwright; Michael P Barrett; Ulo Langel; Ingrid Faye
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

2.  Interaction of monobenzamidine-linked trypanocides with the Trypanosoma brucei P2 aminopurine transporter.

Authors:  Mhairi L Stewart; Cyrille Boussard; Reto Brun; Ian H Gilbert; Michael P Barrett
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

3.  Characterization of a melamino nitroheterocycle as a potential lead for the treatment of human african trypanosomiasis.

Authors:  Federica Giordani; Annamaria Buschini; Alessandro Baliani; Marcel Kaiser; Reto Brun; Michael P Barrett; Claudia Pellacani; Paola Poli; Ian H Gilbert
Journal:  Antimicrob Agents Chemother       Date:  2014-07-14       Impact factor: 5.191

4.  Antibacterial Properties of Four Novel Hit Compounds from a Methicillin-Resistant Staphylococcus aureus-Caenorhabditis elegans High-Throughput Screen.

Authors:  Nagendran Tharmalingam; Rajmohan Rajmuthiah; Wooseong Kim; Beth Burgwyn Fuchs; Elamparithi Jeyamani; Michael J Kelso; Eleftherios Mylonakis
Journal:  Microb Drug Resist       Date:  2018-02-20       Impact factor: 3.431

5.  Exploiting the drug-activating properties of a novel trypanosomal nitroreductase.

Authors:  Belinda S Hall; Xinghua Wu; Longqin Hu; Shane R Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  2009-12-22       Impact factor: 5.191

6.  Selective delivery of 2-hydroxy APA to Trypanosoma brucei using the melamine motif.

Authors:  Nina Klee; Pui Ee Wong; Beatriz Baragaña; Farah El Mazouni; Margaret A Phillips; Michael P Barrett; Ian H Gilbert
Journal:  Bioorg Med Chem Lett       Date:  2010-06-17       Impact factor: 2.823

7.  A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes.

Authors:  Shane R Wilkinson; Martin C Taylor; David Horn; John M Kelly; Ian Cheeseman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-26       Impact factor: 11.205

Review 8.  Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

Authors:  M P Barrett; D W Boykin; R Brun; R R Tidwell
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

9.  Quinone-amino acid conjugates targeting Leishmania amino acid transporters.

Authors:  Federica Prati; Adele Goldman-Pinkovich; Federica Lizzi; Federica Belluti; Roni Koren; Dan Zilberstein; Maria Laura Bolognesi
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

Review 10.  New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story.

Authors:  Emily A Dickie; Federica Giordani; Matthew K Gould; Pascal Mäser; Christian Burri; Jeremy C Mottram; Srinivasa P S Rao; Michael P Barrett
Journal:  Trop Med Infect Dis       Date:  2020-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.